Tuesday, November 18, 2014
Print Current Session:
|
|
Tuesday
SESSION 20:
OPTIMAL PERIPROCEDURAL MEDICAL MANAGEMENT IN VASCULAR PATIENTS; SOME INTERESTING HISTORY AND TECHNOLOGY; THE CCSVI FOR MULTIPLE SCLEROSIS (MS) CONTROVERSY
Moderators:Caron B. Rockman, MD / K. Craig Kent, MD
|
|
SESSION 20 SCHEDULE | |
PERIPROCEDURAL MANAGEMENT, INTERESTING HISTORY AND TECHNOLOGY | |
10:05 AM - 10:10 AM | Periop And Periprocedural Care Is Key For Vascular Patients: What Is Optimal Antiplatelet Treatment; Statin Dosage, Drugs And Loading; And Beta Blockade |
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Abstract | |
10:11 AM - 10:16 AM | Scandalous High Long-Term Mortality After EVAR: It Is Due To MD Ignorance Regarding Statins And Other Medical Treatment: The AAA Is Fixed But MIs Kill: Statins Should Be In The Drinking Water |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
10:17 AM - 10:22 AM | Heparin Management During Open AAA Repair: Is Heparin Necessary For Elective Or Ruptured AAA Repair |
Presenter(s):Arno M. Wiersema, MD | |
View Abstract | |
10:23 AM - 10:28 AM | How Do Statins Influence Long-Term Restenosis And Cardiovascular Events (Stroke And MI) After CEA And After CAS |
Presenter(s):Christos D. Liapis, MD | |
View Abstract | |
10:29 AM - 10:34 AM | Tales From The Crypt: 5000-Year-Old History Of Atherosclerosis (ASO): What It Tells Us About ASO Today |
Presenter(s):Christopher K. Zarins, MD | |
View Abstract | |
10:35 AM - 10:40 AM | What Andreas Gruntzig Said 30 Years Ago And Its Relevance Today |
Presenter(s):Sigrid Nikol, MD | |
View Abstract | |
10:41 AM - 10:46 AM | Shock Wave Lithoplasty For Treating Severely Calcified Occlusive Lesions: Theory And 30-Day CE Mark Study Results |
Presenter(s):Andrew Holden, MBChB | |
View Abstract | |
10:47 AM - 10:53 AM | Panel Discussion |
THE CCSVI FOR MS CONTROVERSY | |
Moderator(s): Lindsay Machan, MD / Manish Mehta, MD, MPH | |
10:53 AM - 10:58 AM | What Is New In CCSVI For MS: The Positive Evidence Mounts: How To Select Patients: Can Brain Perfusion Be Improved: Is Open Vein Repair Ever Needed |
Presenter(s):Paolo Zamboni, MD | |
View Abstract | |
10:59 AM - 11:04 AM | Vein PTA Helps Selected MS Patients With CCSVI: There Is No Doubt: Stem Cell Therapy May Also Be Beneficial |
Presenter(s):Ivo Petrov, MD, PhD | |
View Abstract | |
11:05 AM - 11:10 AM | The Omohyoid Muscle Can Be A Cause Of Venous Compression Leading To CCSVI: Documentation And Relief By Resection |
Presenter(s):Alberto Lomeo, MD | |
View Abstract | |
11:11 AM - 11:16 AM | Regarding CCSVI And MS, A Skeptic’s View |
Presenter(s):J. David Spence, MD | |
View Abstract | |
11:17 AM - 11:22 AM | Despite Some Questions, There Is Still A Relationship Between CCSVI And MS And An Opportunity For A Positive Effect From Endovascular Treatment |
Presenter(s):Michael D. Dake, MD | |
View Abstract | |
11:23 AM - 11:28 AM | The Proper Technique For Venoplasty For CCSVI As A Contributory Cause Of MS: Variability In Technique May Account For Variable Results |
Presenter(s):Donald B. Reid, MD | |
View Abstract | |
11:29 AM - 11:34 AM | Is The CCSVI Concept In MS Valid: Results Of A Meta-analysis |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Abstract | |
11:35 AM - 11:40 AM | The Presence Of Extracranial Venous Narrowing Is The Same In MS Patients And Normal Controls |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
11:41 AM - 11:46 AM | Update On The RCT Of Venous Balloon Angioplasty vs. Venography Placebo: What Does It Tell Us |
Presenter(s):L. Nelson Hopkins, MD / Robert Zivadinov, MD, PhD, FAAN | |
View Abstract | |
11:47 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 20 | |
previous | next |